PROGENICS PHARMACEUTICALS IN's ticker is PGNX and the CUSIP is 743187106. A total of 84 filers reported holding PROGENICS PHARMACEUTICALS IN in Q3 2013. The put-call ratio across all filers is 4.14 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $36,000 | -82.1% | 9,478 | -76.0% | 0.00% | -100.0% |
| Q4 2019 | $201,000 | +74.8% | 39,486 | +73.3% | 0.00% | 0.0% |
| Q3 2019 | $115,000 | -61.3% | 22,785 | -67.8% | 0.00% | -66.7% |
| Q4 2018 | $297,000 | -38.0% | 70,779 | -7.4% | 0.00% | -25.0% |
| Q3 2018 | $479,000 | -6.3% | 76,429 | +20.2% | 0.00% | 0.0% |
| Q2 2018 | $511,000 | +215.4% | 63,566 | +192.0% | 0.00% | +100.0% |
| Q1 2018 | $162,000 | -59.5% | 21,766 | -67.6% | 0.00% | -33.3% |
| Q4 2017 | $400,000 | +23.5% | 67,210 | +52.8% | 0.00% | 0.0% |
| Q3 2017 | $324,000 | +157.1% | 43,990 | +136.1% | 0.00% | +200.0% |
| Q2 2017 | $126,000 | +17.8% | 18,628 | +50.3% | 0.00% | 0.0% |
| Q4 2016 | $107,000 | -7.8% | 12,390 | -32.2% | 0.00% | 0.0% |
| Q3 2016 | $116,000 | -21.1% | 18,266 | -46.0% | 0.00% | -50.0% |
| Q1 2016 | $147,000 | +65.2% | 33,796 | +133.5% | 0.00% | +100.0% |
| Q4 2015 | $89,000 | +345.0% | 14,471 | +305.2% | 0.00% | – |
| Q3 2015 | $20,000 | -92.9% | 3,571 | -90.5% | 0.00% | -100.0% |
| Q2 2015 | $281,000 | +144.3% | 37,651 | +95.0% | 0.00% | +100.0% |
| Q1 2015 | $115,000 | -48.2% | 19,304 | -53.6% | 0.00% | -33.3% |
| Q4 2013 | $222,000 | +3.7% | 41,603 | -2.0% | 0.00% | -25.0% |
| Q3 2013 | $214,000 | +250.8% | 42,450 | +212.5% | 0.00% | +100.0% |
| Q2 2013 | $61,000 | – | 13,584 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| EVERENCE CAPITAL MANAGEMENT INC | 28,980 | $123,000 | 0.01% |
| Daiwa Securities Group Inc. | 533 | $2,000 | 0.00% |
| IFP Advisors, Inc | 0 | $0 | 0.00% |
| NEW YORK STATE TEACHERS RETIREMENT SYSTEM | 138,663 | $52,000 | 0.00% |